These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 36444554

  • 21. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.
    Gibson TM, Mostoufi-Moab S, Stratton KL, Leisenring WM, Barnea D, Chow EJ, Donaldson SS, Howell RM, Hudson MM, Mahajan A, Nathan PC, Ness KK, Sklar CA, Tonorezos ES, Weldon CB, Wells EM, Yasui Y, Armstrong GT, Robison LL, Oeffinger KC.
    Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
    [Abstract] [Full Text] [Related]

  • 22. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
    Herr MM, Schonfeld SJ, Dores GM, Withrow DR, Tucker MA, Curtis RE, Morton LM.
    J Natl Cancer Inst; 2018 Nov 01; 110(11):1248-1258. PubMed ID: 29659938
    [Abstract] [Full Text] [Related]

  • 23. Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma.
    Chang ET, Lau EC, Mowat FS, Teta MJ.
    Cancer Causes Control; 2017 Sep 01; 28(9):971-979. PubMed ID: 28755241
    [Abstract] [Full Text] [Related]

  • 24. Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study.
    Termuhlen AM, Tersak JM, Liu Q, Yasui Y, Stovall M, Weathers R, Deutsch M, Sklar CA, Oeffinger KC, Armstrong G, Robison LL, Green DM.
    Pediatr Blood Cancer; 2011 Dec 15; 57(7):1210-6. PubMed ID: 21384541
    [Abstract] [Full Text] [Related]

  • 25. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
    Holmqvist AS, Chen Y, Berano Teh J, Sun C, Birch JM, van den Bos C, Diller LR, Dilley K, Ginsberg J, Martin LT, Nagarajan R, Nathan PC, Neglia JP, Terenziani M, Tishler D, Meadows AT, Robison LL, Oberlin O, Bhatia S.
    Cancer; 2019 Apr 15; 125(8):1373-1383. PubMed ID: 30556153
    [Abstract] [Full Text] [Related]

  • 26. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
    MacArthur AC, Spinelli JJ, Rogers PC, Goddard KJ, Phillips N, McBride ML.
    Pediatr Blood Cancer; 2007 Apr 15; 48(4):453-9. PubMed ID: 16767718
    [Abstract] [Full Text] [Related]

  • 27. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study.
    Bright CJ, Reulen RC, Winter DL, Stark DP, McCabe MG, Edgar AB, Frobisher C, Hawkins MM.
    Lancet Oncol; 2019 Apr 15; 20(4):531-545. PubMed ID: 30797674
    [Abstract] [Full Text] [Related]

  • 28. Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors Cohort.
    Ramin C, Veiga LHS, Vo JB, Curtis RE, Bodelon C, Aiello Bowles EJ, Buist DSM, Weinmann S, Feigelson HS, Gierach GL, Berrington de Gonzalez A.
    Breast Cancer Res; 2023 May 03; 25(1):50. PubMed ID: 37138341
    [Abstract] [Full Text] [Related]

  • 29. Age-time risk patterns of solid cancers in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden.
    Lorenzo Bermejo J, Pukkala E, Johannesen TB, Sundquist J, Hemminki K.
    Br J Haematol; 2014 Mar 03; 164(5):675-83. PubMed ID: 24528128
    [Abstract] [Full Text] [Related]

  • 30. Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality.
    Parsons MW, Rock C, Chipman JJ, Shah HR, Hu B, Stephens DM, Tao R, Tward JD, Gaffney DK.
    Cancer Med; 2023 Feb 03; 12(3):2624-2636. PubMed ID: 36812123
    [Abstract] [Full Text] [Related]

  • 31. Health care use of long-term survivors of childhood cancer: the British Childhood Cancer Survivor Study.
    Rebholz CE, Reulen RC, Toogood AA, Frobisher C, Lancashire ER, Winter DL, Kuehni CE, Hawkins MM.
    J Clin Oncol; 2011 Nov 01; 29(31):4181-8. PubMed ID: 21947833
    [Abstract] [Full Text] [Related]

  • 32. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
    Tadmor T, Liphshitz I, Silverman B, Polliack A.
    Hematol Oncol; 2017 Dec 01; 35(4):599-607. PubMed ID: 27238496
    [Abstract] [Full Text] [Related]

  • 33. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.
    Xavier AC, Armeson KE, Hill EG, Costa LJ.
    Cancer; 2013 Sep 15; 119(18):3385-92. PubMed ID: 23797978
    [Abstract] [Full Text] [Related]

  • 34. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH.
    Arch Dermatol; 2007 Jan 15; 143(1):45-50. PubMed ID: 17224541
    [Abstract] [Full Text] [Related]

  • 35. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study.
    Bhatti P, Veiga LH, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Weathers R, Leisenring W, Mertens AC, Hammond S, Friedman DL, Neglia JP, Meadows AT, Donaldson SS, Sklar CA, Robison LL, Inskip PD.
    Radiat Res; 2010 Dec 15; 174(6):741-52. PubMed ID: 21128798
    [Abstract] [Full Text] [Related]

  • 36. Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
    van Eggermond AM, Schaapveld M, Janus CP, de Boer JP, Krol AD, Zijlstra JM, van der Maazen RW, Kremer LC, van Leerdam ME, Louwman MW, Visser O, De Bruin ML, Aleman BM, van Leeuwen FE.
    Br J Cancer; 2017 Jul 25; 117(3):306-314. PubMed ID: 28632726
    [Abstract] [Full Text] [Related]

  • 37. Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.
    Marina NM, Liu Q, Donaldson SS, Sklar CA, Armstrong GT, Oeffinger KC, Leisenring WM, Ginsberg JP, Henderson TO, Neglia JP, Stovall MA, Yasui Y, Randall RL, Geller DS, Robison LL, Ness KK.
    Cancer; 2017 Jul 01; 123(13):2551-2560. PubMed ID: 28222219
    [Abstract] [Full Text] [Related]

  • 38. Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study.
    Taylor AJ, Croft AP, Palace AM, Winter DL, Reulen RC, Stiller CA, Stevens MC, Hawkins MM.
    Int J Cancer; 2009 Nov 15; 125(10):2400-5. PubMed ID: 19610069
    [Abstract] [Full Text] [Related]

  • 39. Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.
    Moser EC, Noordijk EM, van Leeuwen FE, Baars JW, Thomas J, Carde P, Meerwaldt JH, van Glabbeke M, Kluin-Nelemans HC.
    Haematologica; 2006 Nov 15; 91(11):1481-8. PubMed ID: 17043014
    [Abstract] [Full Text] [Related]

  • 40. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van der Pal HJ, Loonen JJ, Bresters D, Versluys B, Neggers SJCMM, Jaspers MWM, Hauptmann M, van der Heiden-van der Loo M, Visser O, Kremer LCM, Ronckers CM, DCOG LATER Study Group.
    J Clin Oncol; 2017 Jul 10; 35(20):2288-2298. PubMed ID: 28530852
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.